Last year in my blog I had mentioned something about Sanofi aventis penetration into emerging markets which include Latin American countries, India and China. For instance in Latin America it went into Merger and Acquisition of generic, India in similar way for acquisition of Shanta Biotech Hyderabad based Bio similar company and in China it went into to open its R&D centre for Biologics and generic production and now last week in a press release it was mentioned that Sanofi Aventis in going to invest around 5 Billion Yen in Japanese generic company Nichi- Iko Pharmaceutical.........now I guess next thing is that the company will try to strategize its marketing in South Asia..................
Good one
ReplyDelete